International Business Machines (IBM) has moved from a weak pullback to a positive balance of evidence after its October 21 earnings. The stock fell about 7% in morning trading on October 22 despite a beat, then recovered to $255.74, up 8.2% in five days and back above its 40-week average. The weekly trend and relative strength now agree. The rally is stretched, and the breakout math stops short of 3 to 1.
Why it matters
The quarter itself was good. IBM reported revenue of $17.1 billion, adjusted earnings of $2.95 per share, reaffirmed its 4% to 5% constant-currency revenue growth guidance and raised its free cash flow outlook. Software revenue grew 9%, and the operating pretax margin widened by 70 basis points while earnings per share rose about 25%. On the numbers alone, this was a clean beat.
The market reacted to a sentence, not the numbers. TheStreet reported that shares fell about 7% on October 22 after CEO Arvind Krishna said large enterprises are weighing the "true ROI" of AI spending. Whatever the quarter showed, the stock had been priced for reassurance on AI demand and got a question instead. On the earnings call Krishna added that open-weight models deliver roughly 90% of the effectiveness of frontier models at 10% to 25% of the token cost, as Yahoo Finance reported. That is an argument for IBM's role as an integrator of cheaper models, and it was not enough to stop the initial drop.
The five-day move belongs almost entirely to the stock. IBM is up 8.2% while the S&P 500 is down 0.4% and the technology sector ETF (XLK) is down 0.9%, so IBM is about 9.1 points ahead of its sector. Over the past month the gap is wider: IBM is up 13.4% and XLK is down 6.1%. Today is different. IBM's 0.9% gain sits alongside 0.7% for both the S&P 500 and XLK, so the market is helping. The news explains the drop but not the rebound that followed. The only pointer is a WSJ podcast headline about "IBM's comeback", with no detail available.
The argument over IBM is about quality of growth. The skeptic's case, in a Yahoo Finance opinion piece, calls IBM America's worst big tech company, setting 5% revenue growth to $17.1 billion against Microsoft's $90 billion quarter. The supportive case is about cash and income. Another Yahoo Finance article groups IBM with four other mega-caps yielding 2.2% to 2.9%, with dividends covered by free cash flow. A Seeking Alpha review sits in between and keeps a "Do Nothing" opinion. On valuation, 23 analysts rate the stock a buy on consensus, with a mean price target of $257.22 and a range from $174 to $300. At $255.74 the stock trades 0.6% below that mean, so the consensus leaves little upside from here.
What the evidence says
The previous report, on October 21, 2026, was bearish with low conviction. Price was below its 40-week average, the weekly trend pointed down, and the move was a pullback within it. A weekly close above $329.23, the 52-week high, was the level that would have overturned it. That reading has changed. Price is now above both its 10-week and 40-week averages, and the daily trend runs with the weekly uptrend. The long-term thesis is repaired rather than restored. The stock is still 13.7% lower for the year and 22.3% below its 52-week high, and it has only just climbed back over its 200-day average at $250.22. The phase is an early recovery from a deep drawdown.
For the next 2 to 6 weeks the balance of evidence leans positive, and conviction is high, at 3 of 4 points. The reasons are the aligned daily and weekly trends, and strength against the market and the sector. IBM leads the S&P 500 by 10.1% over 50 days and XLK by 12.3%. The strongest case against this reading is how stretched the move is. The 14-day RSI is 87.45, the stock gained 8.2% in five days, and today's close is its recent peak. It is also within 0.6% of the mean analyst target. Over 200 days IBM still trails the S&P 500 by 3.1%. Volume is running well below its 20-day average, though that figure is from early in the session and says little yet. These points do not undo the trend and relative-strength evidence. They are why conviction is not 4 of 4, and they make a pause or pullback toward support a normal outcome.
Levels that matter
The structure holds above $250.91, a swing zone that sits just over the 200-day average at $250.22. A move under it would be the first crack. The trend ends on a weekly close below $242.1, the next swing zone. Below that, support stacks up at $234.66, the 50-day average at $233.47 and $228.96.
The breakout level is a daily close above $275.00 on volume above its 20-day average. From there the nearest ceiling is the $300 round number, and the target is the 52-week high at $329.23. The breakout would be wrong below $249.03, which is the $250.91 zone less a quarter of the 7.51 daily average range. That gives 2.1 to 1, short of the 3 to 1 that makes a breakout worth the risk. A 3 to 1 ratio would need an entry near $269, which sits under the breakout level itself, or a target above the 52-week high.
What would change the picture
A weekly close below $242.1 would end the weekly uptrend and put the earlier bearish reading back in play. The non-price fact that would most likely do it is a cut to the 4% to 5% constant-currency revenue guidance, or software growth slipping from 9%. Either would confirm the worry about enterprise AI returns that drove the 7% drop.
What to watch
- Next earnings: the date is not yet confirmed. The last report was October 21, 2026. The number that matters is software revenue growth, which was 9%.
- Sector: megacap earnings weighed on the Nasdaq last week, with the Nasdaq Composite down 0.45% and the Nasdaq volatility index at 28.13, per Yahoo Finance. Meta's first quarterly cash burn since its IPO year, covered by Yahoo Finance, keeps the AI spending question alive. XLK is down 6.1% over the month and can move IBM before its own news.
- Valuation: the stock at $255.74 against a mean target of $257.22 and a $174 to $300 range. The consensus has caught up with the price.